SCHEMBL6984894

SCHEMBL6984894

CN(c1ccc2ncccc2c1)S(=O)(=O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.56
HTT P42858 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
NAMPT P43490 1/20 0.50
NR1I2 O75469 1/20 0.50
GAA P10253 1/20 0.49
DOT1L Q8TEK3 1/20 0.48
GPR55 Q9Y2T6 1/20 0.47
BCAT1 P54687 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
F2 P00734 1/20 0.46
CA12 O43570 1/20 0.45
CA9 Q16790 1/20 0.45
ALDH1A1 P00352 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
NR1H3 Q13133 1/20 0.44
LMNA P02545 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7956823 0.77 NR1I2 (0.55) L3MBTL1NAMPTNR1I2GPR55BCAT1
SCHEMBL14718512 0.76 ALDH1A1 (0.55) HTTNAMPTGAADOT1LMEN1
SCHEMBL17335810 0.75 DOT1L (0.63) L3MBTL1HTTDOT1LMEN1KMT2A
SCHEMBL29418293 0.74 DOT1L (0.61) L3MBTL1HTTDOT1LMEN1KMT2A
SCHEMBL826341 0.74 DOT1L (0.61) L3MBTL1HTTDOT1LMEN1KMT2A
SCHEMBL14507082 0.74 NR1I2 (0.51) L3MBTL1NR1I2GAAMEN1KMT2A
SCHEMBL19476154 0.74 NAMPT (0.71) HTTNAMPTBCAT1MEN1KMT2A
SCHEMBL6983882 0.74 ALDH1A1 (0.48) HTTNAMPTNR1I2BCAT1ALDH1A1
SCHEMBL15480616 0.74 HDAC6 (0.55) HTTNAMPTGAAGPR55BCAT1
SCHEMBL6984896 0.74 ABCB1 (0.59) HTTGAAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed